KLWA
AGN

Kelly Lawrence W & Associates’s Allergan Inc AGN Stock Holding History

Kelly Lawrence W & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,375
Closed -$1.78M – 138
2014
Q4 		$1.78M Sell
8,375
-700
-8% -$139K 0.37% 42
2014
Q3 		$1.62M Sell
9,075
-125
-1% -$20.8K 0.34% 43
2014
Q2 		$1.56M Sell
9,200
-12,850
-58% -$2M 0.33% 43
2014
Q1 		$2.74M Sell
22,050
-300
-1% -$36.5K 0.63% 38
2013
Q4 		$2.48M Sell
22,350
-1,025
-4% -$97.9K 0.55% 40
2013
Q3 		$2.11M Sell
23,375
-25
-0.1% -$2.24K 0.5% 40
2013
Q2 		$1.97M Buy
+23,400
New +$2.43M 0.5% 40

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Kelly Lawrence W & Associates's AGN Position: Q1 2015 in Review

Kelly Lawrence W & Associates sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 8,375 shares — an estimated $1.78M sold.

Kelly Lawrence W & Associates first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.74M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Kelly Lawrence W & Associates reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 8,375 Allergan Inc shares in Q1 2015, an estimated $1.78M.
  • Kelly Lawrence W & Associates first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Kelly Lawrence W & Associates's Allergan Inc position peaked at $2.74M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Kelly Lawrence W & Associates's 13F filing for Q1 2015, filed 14 May 2015.